Sun, Feb 18, 2018
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Systematic hedge fund group Cantab Capital names Dr Matthew Killeya and Dr Genia Diamond partners

Monday, April 08, 2013

Dr. Ewan Kirk
Opalesque Industry Update - Cantab Capital Partners, the systematic global macro manager has announced that Dr Matthew Killeya (Senior Scientist) and Dr. Genia Diamond (Head of Business Development), have been named partners in the firm.

The announcement is in recognition of Dr. Killeya’s and Dr.Diamond’s contribution to Cantab’s business success and growth. Genia has lead the Investor Relations team that has overseen Cantab’s assets increase fivefold to USD 5,3 billion since 2011.

Matthew’s primary focus is on investment strategy development, having contributed strategies in all three of the clusters within the portfolio (momentum, value and short term).

Commenting on the move, Dr. Ewan Kirk said: “Our investors know that we take both our investment models and investor relations immensely seriously. Both Genia and Matthew have contributed significantly to these respective functions, as well as the overall development of Cantab. As a result we are truly pleased they have accepted our offer to join the partnership.”

Press release

Cantab Capital Partners LLP is a $5.3 billion total assets under management systematic global macro manager based in Cambridge, England. Cantab was founded in 2006 by Dr Ewan Kirk (ex-Goldman Sachs), Erich Schlaikjer (ex-Goldman Sachs) and Chris Pugh (ex-KBC). Dr Tom Howat became a Partner in 2011. The investor base is 60% institutional, 35% fund of funds, and 5% family offices/high net worth individuals. www.cantabcapital.com

Dr Genia Diamond – Head of Business Development
Genia leads the team responsible for all investor-related activities helping to further expand the firm’s reputation and place amongst investors globally.

Genia joined Cantab from OMAM UK and prior to that she was at Solent Capital and BlueCrest Capital. She started her career in asset management as a senior HF researcher at PAAMCO. Genia has a PhD in linguistics from the Moscow State University, an MBA from Erasmus University in the Netherlands and achieved an MA (honours) in Linguistics & Culture Studies from the Moscow State University.

Dr Matthew Killeya – Senior Scientist
Matthew works on all aspects of programme and portfolio construction and has driven developments in these areas, including contributing several new strategies to the portfolio.

More recently Matt’s focus has been on short term execution algorithms and strategies to trade options as a natural diversifier to the futures strategies.

Previously Matt was a senior managing researcher at Winton Capital Management for five years. Matt has a PhD in Bayesian statistics from Durham University. Prior to that, Matt obtained a first class Master of Mathematics degree, also from Durham University.

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Chenavari, a $5.4bn hedge fund, told investors it thinks 'we could experience a similar pattern as the 1987 crash'[more]

    From Businessinsider.com: A $5.4 billion hedge fund told clients markets could tumble just like they did in the 1987 crash. In a February 14 letter to clients, London-based Chenavari Investment Managers warned about current market conditions. From the letter (emphasis added): "Our view is that

  2. Active funds shone in selloff, just like they said they would[more]

    From Bloomberg.com: For years, it's been the same refrain. Don't bail on active management, you'll regret it when the market turns sour. And while the selloff that ripped through equities this month has been too short to prove anything, early returns suggest they had a point. Thanks to differentiate

  3. No place to hide: managed futures funds fall with stocks[more]

    From Barrons.com: Managed futures mutual funds haven't lived up to their billing of providing uncorrelated returns so far in 2018, continuing a disappointing multiyear stretch. The $10 billion AQR Managed Futures Strategy, the largest fund by a wide margin in the category, was down 2.75% year-to-dat

  4. Investing - Hedge fund Bridgewater makes $22 billion bet against European firms, Hedge funds Steadfast and Suvretta jump onto CSX in fourth quarter, Tepper's Appaloosa boosts Apple, Facebook as others bolt, Third Point buys Netflix and MGM, dumps Bank of America, Moore Capital bought Wynn Resorts, other casino stocks before Steve Wynn resigned[more]

    Hedge fund Bridgewater makes $22 billion bet against European firms From Reuters/USNews.com: Bridgewater has shown its hand in Europe with a $22 billion bet against some of the continent's biggest companies, filings reviewed by Reuters show, part of a bigger shift by the world's largest

  5. Funds Profiles - Brother-run hedge fund up 46% in 2017 says Kelly formula shows diversification is flawed, How a 6,000% profit on a single trade saved a small hedge fund from disaster[more]

    Brother-run hedge fund up 46% in 2017 says Kelly formula shows diversification is flawed From Valuewalk.com: When Jeremy and Michael Kahan consider the notion of diversification, the wince. With a return of 45.8% to end 2017, their stock-picking fund, North Peak Capital, successfully